Clinical Trial Update: Modulation of Cerebral Ischemia by Albumin [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether albumin can modulate cerebral ischemia in ischemic stroke; currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Albumin

Snippet

Sponsor: University Hospital Hradec Kralove | Conditions: Ischemic Stroke | Phase 2 | Status: NOT_YET_RECRUITING